BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32849555)

  • 41. Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: reversal by addition of bovine serum albumin.
    Moppett J; van der Velden VH; Wijkhuijs AJ; Hancock J; van Dongen JJ; Goulden N
    Leukemia; 2003 Jan; 17(1):268-70. PubMed ID: 12529693
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
    Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
    Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unusual T-cell receptor-delta gene rearrangement patterns revealed by screening of a large series of childhood acute lymphoblastic leukaemia by multiplex polymerase chain reaction.
    Seeger K; Taube T; Eckert C; Hanel C; Pogodda M; Henze G
    Br J Haematol; 2001 May; 113(2):318-22. PubMed ID: 11380394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-time quantitative PCR: standardized detection of minimal residual disease in pediatric acute lymphoblastic leukemia. Polymerase chain reaction.
    Pine SR; Moy FH; Wiemels JL; Gill RK; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C; Jayabose S
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):103-8. PubMed ID: 12571459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.
    Pongers-Willemse MJ; Seriu T; Stolz F; d'Aniello E; Gameiro P; Pisa P; Gonzalez M; Bartram CR; Panzer-Grümayer ER; Biondi A; San Miguel JF; van Dongen JJ
    Leukemia; 1999 Jan; 13(1):110-8. PubMed ID: 10049045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.
    Hoffmann J; Krumbholz M; Gutiérrez HP; Fillies M; Szymansky A; Bleckmann K; Zur Stadt U; Köhler R; Kuiper RP; Horstmann M; von Stackelberg A; Eckert C; Metzler M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27780. PubMed ID: 31034759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL.
    Szczepański T; van der Velden VH; Raff T; Jacobs DC; van Wering ER; Brüggemann M; Kneba M; van Dongen JJ
    Leukemia; 2003 Nov; 17(11):2149-56. PubMed ID: 14576730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; von dem Borne AE; van der Schoot CE
    Leukemia; 1995 Jan; 9(1):216-22. PubMed ID: 7845021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification by antigen-receptor gene sequences.
    Roberts WM; Estrov Z; Kitchingman GR; Zipf TF
    Leuk Lymphoma; 1996 Jan; 20(3-4):181-97. PubMed ID: 8624456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
    Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
    Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye.
    Li AH; Forestier E; Rosenquist R; Roos G
    Exp Hematol; 2002 Oct; 30(10):1170-7. PubMed ID: 12384148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection and monitoring of minimal residual disease by quantitative real-time PCR.
    Schüler F; Dölken G
    Clin Chim Acta; 2006 Jan; 363(1-2):147-56. PubMed ID: 16154122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions.
    Seriu T; Hansen-Hagge TE; Erz DH; Bartram CR
    Leukemia; 1995 Feb; 9(2):316-20. PubMed ID: 7869770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigen Selection Shapes the T-cell Repertoire in Chronic Lymphocytic Leukemia.
    Vardi A; Agathangelidis A; Stalika E; Karypidou M; Siorenta A; Anagnostopoulos A; Rosenquist R; Hadzidimitriou A; Ghia P; Sutton LA; Stamatopoulos K
    Clin Cancer Res; 2016 Jan; 22(1):167-74. PubMed ID: 26338994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34).
    Yamamoto K; Nakamachi Y; Yakushijin K; Miyata Y; Okamura A; Kawano S; Matsuoka H; Minami H
    Eur J Haematol; 2013 Jan; 90(1):68-75. PubMed ID: 23033986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. One-Step Next-Generation Sequencing of Immunoglobulin and T-Cell Receptor Gene Recombinations for MRD Marker Identification in Acute Lymphoblastic Leukemia.
    Villarese P; Abdo C; Bertrand M; Thonier F; Giraud M; Salson M; Macintyre E
    Methods Mol Biol; 2022; 2453():43-59. PubMed ID: 35622319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative assessment of minimal residual disease in childhood lymphoid malignancies using an allele-specific oligonucleotide real-time quantitative polymerase chain reaction.
    Tarusawa M; Yashima A; Endo M; Maesawa C
    Int J Hematol; 2002 Feb; 75(2):166-73. PubMed ID: 11939263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.
    Macintyre EA; d'Auriol L; Duparc N; Leverger G; Galibert F; Sigaux F
    J Clin Invest; 1990 Dec; 86(6):2125-35. PubMed ID: 2174915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitation of leukemia clone-specific antigen gene rearrangements by a single-step PCR and fluorescence-based detection method.
    Mayer SP; Giamelli J; Sandoval C; Roach AS; Fevzi Ozkaynak M; Tugal O; Rovera G; Jayabose S
    Leukemia; 1999 Nov; 13(11):1843-52. PubMed ID: 10557060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.
    Garand R; Beldjord K; Cavé H; Fossat C; Arnoux I; Asnafi V; Bertrand Y; Boulland ML; Brouzes C; Clappier E; Delabesse E; Fest T; Garnache-Ottou F; Huguet F; Jacob MC; Kuhlein E; Marty-Grès S; Plesa A; Robillard N; Roussel M; Tkaczuk J; Dombret H; Macintyre E; Ifrah N; Béné MC; Baruchel A
    Leukemia; 2013 Feb; 27(2):370-6. PubMed ID: 23070018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.